Evidence map›Paper›PMID 36126728›Full record

ArticleNeuropharmacology2022

14-3-3γ mediates the long-term inhibition of peripheral kappa opioid receptor antinociceptive signaling by norbinaltorphimine.

Michael J Wedemeyer, Elaine M Jennings, Hudson R Smith, Teresa S Chavera, Raehannah J Jamshidi, Kelly A Berg, William P Clarke

Open access · greenAbstract read
In one paragraph

Article in Neuropharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Michael J WedemeyerDepartment of Pharmacology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
Elaine M JenningsDepartment of Pharmacology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
Hudson R SmithDepartment of Pharmacology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
Teresa S ChaveraDepartment of Pharmacology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
Raehannah J JamshidiDepartment of Pharmacology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
Kelly A BergDepartment of Pharmacology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
William P ClarkeDepartment of Pharmacology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA. Electronic address: clarkew@uthscsa.edu.
The University of Texas Health Science Center at San Antonio · US

Funding

Training in Drug Abuse Research: Behavior and NeurobiologyT32DA031115 · NIDA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI CHARLES P FRANCE · 2011 to 2026
$5.2M
KOR Agonist Functional Selectivity in Peripheral Sensory NeuronsR01DA038645 · NIDA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI BERG, KELLY ANN, CLARKE, WILLIAM P · 2015 to 2019
$2.8M
NIDA NIH HHS R01 DA038645NIDA NIH HHS T32 DA031115
6 · The paper itself

Abstract

Long-term inhibition of kappa opioid receptor (KOR) signaling in peripheral pain-sensing neurons is a potential obstacle for development of peripherally-restricted KOR agonists that produce analgesia. Such a long-term inhibitory mechanism is invoked from activation of c-Jun N-terminal kinase (JNK) that follows a single injection of the KOR antagonist norbinaltorphimine (norBNI). This effect requires protein synthesis of an unknown mediator in peripheral pain-sensing neurons. Using 2D difference gel electrophoresis with tandem mass spectrometry, we have identified that the scaffolding protein 14-3-3γ is upregulated in peripheral sensory neurons following activation of JNK with norBNI. Knockdown of 14-3-3γ by siRNA eliminates the long-term reduction in KOR-mediated cAMP signaling by norBNI in peripheral sensory neurons in culture. Similarly, knockdown of 14-3-3γ in the rat hind paw abolished the norBNI-mediated long-term reduction in peripheral KOR-mediated antinociception. Further, overexpression of 14-3-3γ in KOR expressing CHO cells prevented KOR-mediated inhibition of cAMP signaling. These long-term effects are selective for KOR as heterologous regulation of other receptor systems was not observed. These data suggest that 14-3-3γ is both necessary and sufficient for the long-term inhibition of KOR by norBNI in peripheral sensory neurons.

Indexed as

JNK Mitogen-Activated Protein KinasesReceptors, Opioid, kappa14-3-3 ProteinsAnalgesicsAnimalsCricetinaeCricetulusNaltrexonePainRatsRNA, Small Interfering14-3-3 ProteinsAnalgesicsJNK Mitogen-Activated Protein KinasesNaltrexonenorbinaltorphimineReceptors, Opioid, kappaRNA, Small Interfering14-3-3γKappa opioid receptorNorbinaltorphimineOpioidsPainSensory neurons

Identifiers

PMID36126728
PMCPMC13015901
OpenAlexW4296312504

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.